Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
Keywords:
Plasma
Amyloid-beta
FDG-PET
Biomarker
Preclinical Alzheimer’s disease
Amyloid-PET
Mild cognitive impairment
Publisher:
Springer Science and Business Media LLC
Note:
This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Citation:
Pérez-Grijalba, V. (Virginia); Arbizu, J. (Javier); Romero, J. (Judith); et al. "Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study". Alzheimer's Research & Therapy. 11 (96), 2019, 2019
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.